Ken Vroman insider trades: Cme Group (CME) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ken reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | CME | ↓ Sell | 5,160 | $309.00 | $1.6M | Direct | Mar 12, 2026 (0d) |
| Feb 13, 2025 | CME | ↓ Sell | 5,066 | $250.00 | $1.3M | Direct | Feb 14, 2025 (1d) |
| Sep 12, 2022 | CME | ↓ Sell | 750 | $201.41 | $151K | Direct | Sep 13, 2022 (1d) |
| Nov 9, 2021 | CME | ↓ Sell | 445 | $220.00 | $98K | Direct | Nov 12, 2021 (3d) |
| Nov 2, 2020 | CME | ↓ Sell | 4,541 | $152.63 | $693K | Direct | Nov 3, 2020 (1d) |
| Mar 12, 2013 | CME | ↓ Sell | 1,492 | $62.69 | $94K | Direct | Mar 13, 2013 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CME insiders
Open-market trades in the last 12 months
About Ken Vroman's insider trades
Ken Vroman is Chief Transformation Officer at Cme Group (CME). Since Mar 12, 2013, Ken has reported no open-market purchases and 6 sales worth $3.9M on SEC Form 4. In the last 12 months: 1 sale ($1.6M).
Their filings also include shares withheld for taxes (23 filings), grants and awards (20 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CME insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.